Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 45^th Annual Global Healthcare Conference on Wednesday, June 12^th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine and John Reed, Executive Vice President, Innovative Medicine R&D will represent the Company in a session scheduled at 2:00 pm (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240508472086/en/

The Johnson & Johnson Stock at the time of publication of the news with a raise of +0,24 % to 138,6EUR on Lang & Schwarz stock exchange (08. Mai 2024, 22:35 Uhr).